Sven Ante Lundberg Transaction History

Date Transaction Value Shares Traded Form
Oct 24 2016
BUY
Open market or private purchase
$5,600 $14.0 p/Share
400

Also insider at

VOR
Vor Biopharma Inc. Healthcare
MRUS
Merus N.V. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
SAL

Sven Ante Lundberg

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP